Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Change in Intangibles (2023 - 2024)

Mirum Pharmaceuticals (MIRM) has 2 years of Change in Intangibles data on record, last reported at $10.0 million in Q3 2024.

  • For Q3 2024, Change in Intangibles changed N/A year-over-year to $10.0 million; the TTM value through Dec 2025 reached $10.0 million, down 50.0%, while the annual FY2024 figure was $20.0 million, 0.0% changed from the prior year.
  • Change in Intangibles reached $10.0 million in Q3 2024 per MIRM's latest filing, roughly flat from $10.0 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $15.0 million in Q1 2023 and bottomed at $5.0 million in Q4 2023.